Does TILDRAKIZUMAB-ASMN Cause Psoriasis? 86 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 86 reports of Psoriasis have been filed in association with TILDRAKIZUMAB-ASMN. This represents 5.3% of all adverse event reports for TILDRAKIZUMAB-ASMN.
86
Reports of Psoriasis with TILDRAKIZUMAB-ASMN
5.3%
of all TILDRAKIZUMAB-ASMN reports
0
Deaths
3
Hospitalizations
How Dangerous Is Psoriasis From TILDRAKIZUMAB-ASMN?
Of the 86 reports, 3 (3.5%) required hospitalization.
Is Psoriasis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TILDRAKIZUMAB-ASMN. However, 86 reports have been filed with the FAERS database.
What Other Side Effects Does TILDRAKIZUMAB-ASMN Cause?
Product dose omission issue (363)
Drug ineffective (223)
Death (84)
Product storage error (74)
Self-medication (74)
Off label use (66)
Condition aggravated (63)
Rash (54)
Pruritus (52)
Therapy cessation (50)
What Other Drugs Cause Psoriasis?
SECUKINUMAB (21,976)
APREMILAST (19,255)
ADALIMUMAB (16,698)
ETANERCEPT (10,818)
RISANKIZUMAB-RZAA (6,896)
METHOTREXATE (6,283)
USTEKINUMAB (4,955)
INFLIXIMAB (3,524)
CERTOLIZUMAB PEGOL (3,428)
IXEKIZUMAB (2,818)
Which TILDRAKIZUMAB-ASMN Alternatives Have Lower Psoriasis Risk?
TILDRAKIZUMAB-ASMN vs TILIDINE
TILDRAKIZUMAB-ASMN vs TIMOLOL
TILDRAKIZUMAB-ASMN vs TIMOLOL\TRAVOPROST
TILDRAKIZUMAB-ASMN vs TINIDAZOLE
TILDRAKIZUMAB-ASMN vs TINZAPARIN